[Immunosuppressive agent FTY720].
Kobayakawa
T
T
YOSHITOMI Pharmaceutical Industries, Ltd., Osaka, Japan. kobayakawa@yoshitomi.co.jp
Chiba
K
K
D000208:Acute Disease; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D016572:Cyclosporine / Q000627:therapeutic use; D015195:Drug Design; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D011409:Propylene Glycols / Q000494:pharmacology / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016572:Cyclosporine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine